Here, we describe the effect of two molecules, cetuximab and HT, a polyphenol from olive oil, that impair the EGF/EGFR oncogenic drive, yielding a reduced proliferation of colon cancer cells (see Figure 10). The gene discussed is EGFR; the disease is colonic neoplasm.